Meeting
2019 ASCO Annual Meeting
Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.
Authors
Thiru Prasanna
University of Canberra, Canberra, ACT, Australia
Thiru Prasanna , Rachel Wong , Timothy Jay Price , Jeremy David Shapiro , Jeanne Tie , Hui-Li Wong , Louise M. Nott , David Roder , Margaret Lee , Suzanne Kosmider , Azim Jalali , Matthew E. Burge , Robert Padbury , Guy Maddern , James Moore , Scott Carruthers , Michael Sorich , Christos Stelios Karapetis , Peter Gibbs , Desmond Yip
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3531)
DOI
10.1200/JCO.2019.37.15_suppl.3531
Abstract #
3531
Poster Bd #
23
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Metastases resection in colorectal cancer patients with mutation in oncogene BRAF or tumors located on the right side: Experience at the HGUGM.
First Author: Laura Ortega
Poster
2020 ASCO Virtual Scientific Program
The impact of BRAF mutation status on clinical outcomes with single-agent PD-1 inhibitor versus combination ipilimumab/nivolumab.
First Author: Vincent The-Luc Ma
Poster
2018 Gastrointestinal Cancers Symposium
PROX: Primary resistance to oxaliplatin containing regimen in the first line treatment of metastatic colorectal carcinoma—Retrospective analysis.
First Author: Larissa Machado
Poster
2011 ASCO Annual Meeting
KRAS and BRAF mutation analysis on paired biopsy and resection specimens of patients with colorectal cancer: Molecular analysis using high-resolution melting, direct sequencing, KRAS ARMS-scorpion PCR and BRAF pyrosequencing.
First Author: L. C. Krol